GLP-1 receptor agonist: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving GLP-1 receptor agonist

• Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM
  NCT06256419 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years to 70 Years · Sex: All (male and female) · 1 location
• Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy
  NCT06903923 · Phase: Phase 2 · Ages: 12 Years to 21 Years · Sex: All (male and female) · 1 location
• Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS
  NCT06889454 · Phase: Not specified · Ages: 18 Years to 45 Years · Sex: Female · 1 location
• Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
  NCT07309094 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• Impact GLP-1 Agonists Following Bariatric
  NCT06132477 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
  NCT05390892 · Phase: Phase 4 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 36 locations

Common questions

How many recruiting trials involve GLP-1 receptor agonist?

6 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.